10 X Fund, L.P. is > 10% Shareholder of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 5.61 Million shares of GALT, which is worth approximately $30.9 Million. The most recent transaction as insider was on Dec 16, 2025, when has been sold 30,681 shares (Common Stock) at a price of $6.66 per share, resulting in proceeds of $204,335. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.61M
8.99% 3M change
8.99% 12M change
Total Value Held $30.9 Million

10X Fund, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2025
SELL
Open market or private sale
$204,335 $6.66 p/Share
30,681 Reduced 0.54%
5,614,457 Common Stock
Dec 03 2025
SELL
Open market or private sale
$687,600 $5.73 p/Share
120,000 Reduced 2.07%
5,682,207 Common Stock
Dec 02 2025
SELL
Open market or private sale
$164,100 $5.47 p/Share
30,000 Reduced 0.51%
5,802,207 Common Stock
Nov 24 2025
SELL
Other acquisition or disposition
-
24,000 Reduced 0.42%
5,645,138 Common Stock
Nov 11 2025
SELL
Open market or private sale
$210,000 $5.25 p/Share
40,000 Reduced 0.68%
5,832,207 Common Stock
Oct 22 2025
SELL
Open market or private sale
$247,000 $4.94 p/Share
50,000 Reduced 0.84%
5,872,207 Common Stock
Jul 22 2022
SELL
Open market or private sale
$20,900 $2.09 p/Share
10,000 Reduced 0.16%
6,168,940 Common Stock
Feb 02 2022
SELL
Open market or private sale
$21,000 $2.1 p/Share
10,000 Reduced 0.16%
6,178,940 Common Stock
Jan 11 2022
SELL
Open market or private sale
$21,000 $2.1 p/Share
10,000 Reduced 0.16%
6,188,940 Common Stock
Dec 02 2021
SELL
Open market or private sale
$23,700 $2.37 p/Share
10,000 Reduced 0.16%
6,198,940 Common Stock
Nov 01 2021
SELL
Open market or private sale
$31,900 $3.19 p/Share
10,000 Reduced 0.16%
6,208,940 Common Stock
Oct 15 2021
SELL
Open market or private sale
$33,700 $3.37 p/Share
10,000 Reduced 0.16%
6,218,940 Common Stock
Oct 04 2021
SELL
Open market or private sale
$36,200 $3.62 p/Share
10,000 Reduced 0.16%
6,228,940 Common Stock
Sep 01 2021
SELL
Open market or private sale
$39,100 $3.91 p/Share
10,000 Reduced 0.16%
6,238,940 Common Stock
Aug 02 2021
SELL
Open market or private sale
$32,500 $3.25 p/Share
10,000 Reduced 0.16%
6,248,940 Common Stock
Jul 09 2021
SELL
Open market or private sale
$35,400 $3.54 p/Share
10,000 Reduced 0.16%
6,258,940 Common Stock
Jun 01 2021
SELL
Open market or private sale
$39,100 $3.91 p/Share
10,000 Reduced 0.16%
6,268,940 Common Stock
May 03 2021
SELL
Open market or private sale
$38,400 $3.84 p/Share
10,000 Reduced 0.16%
6,288,940 Common Stock
Apr 26 2021
SELL
Open market or private sale
$33,525 $4.47 p/Share
7,500 Reduced 0.12%
6,298,940 Common Stock
Apr 23 2021
SELL
Open market or private sale
$19,750 $3.95 p/Share
5,000 Reduced 0.08%
6,306,440 Common Stock
Apr 22 2021
SELL
Open market or private sale
$17,600 $3.52 p/Share
5,000 Reduced 0.08%
6,311,440 Common Stock
Apr 01 2021
SELL
Open market or private sale
$21,600 $2.16 p/Share
10,000 Reduced 0.16%
6,316,440 Common Stock
Mar 01 2021
SELL
Open market or private sale
$23,100 $2.31 p/Share
10,000 Reduced 0.16%
6,326,440 Common Stock
Feb 02 2021
SELL
Open market or private sale
$20,400 $2.04 p/Share
10,000 Reduced 0.16%
6,336,440 Common Stock
Jan 04 2021
SELL
Open market or private sale
$22,300 $2.23 p/Share
10,000 Reduced 0.16%
6,346,440 Common Stock
1FL

10 X Fund, L.P.

> 10% Shareholder
Atlanta, GA

Track Institutional and Insider Activities on GALT

Follow GALECTIN THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GALT shares.

Notify only if

Insider Trading

Get notified when an Galectin Therapeutics Inc insider buys or sells GALT shares.

Notify only if

News

Receive news related to GALECTIN THERAPEUTICS INC

Track Activities on GALT